Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effects of Tarragon Powder on Glucose Metabolic Changes, Lipid Profile and Antioxidant Enzyme Levels in Type 2 Patients With Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial Publisher



Haghighian HK1 ; Shiran M2 ; Akha O3 ; Ghafouri Z4 ; Ghaedi E5 ; Bayat S3 ; Mazloomi MA6 ; Houshmand G7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Nutrition, Faculty of Health, Qazvin University of Medical Sciences, Qazvin, Iran
  2. 2. Department of Pharmacology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  3. 3. Department of Internal Medicine, Diabetes Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  4. 4. Department of Biochemistry, Biophysics and Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  5. 5. Department of Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Student Research Committee, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  7. 7. Department of Pharmacology, Immuno-Genetics Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Source: Jundishapur Journal of Natural Pharmaceutical Products Published:2021


Abstract

Background: The antioxidant and anti-inflammatory properties of tarragon make it known as an antidiabetic plant. Diabetes mellitus, an endocrine, metabolic disease, is a leading global health emergency and associated with serious complications. Objectives: This study aimed to assess the effects of tarragon powder supplementation on glucose metabolism, lipid profile, and antioxidant status in the diabetic population. Methods: Patient screening and selection for this clinical trial lasted one month. Tarragon supplement consumption by patients lasted 2 months (8 weeks); meanwhile, they were followed up. Sixty male and female patients with type 2 diabetes were randomly assigned to the tarragon receiver group (n = 30) and placebo receiver group (n = 30). The intervention group received a tarragon capsule (500 mg) 3 times a day, and the control group received placebo capsules. Fasting blood glucose (FBG), two-hour postprandial glucose (2-hpp), glycated hemoglobin (HbA1c), insulin, lipid, and antioxidant profile were evaluated at the start and the end of the research. Results: In the tarragon receiver group, FBG, 2-hpp, HbA1c%, insulin resistance, lipid, and antioxidant profile significantly improved, compared to the placebo group, after adjuvant therapy with tarragon (P < 0.05). Conclusions: Supplementation with tarragon powder in type II patients with diabetes for 2 months exerts a beneficial effect on improving the glycemic profile, lipid profile, and antioxidant status. Copyright © 2021, Author(s).